Eu­rope's new in­vest­ment firm says it's on a mis­sion to lift up the con­ti­nen­t's 'un­der­ex­ploit­ed' sci­ence

Like many, Alexan­dre Moura­di­an saw the Covid-19 pan­dem­ic as a wake-up call. More dis­ease emer­gen­cies are com­ing, he said, and he want­ed to do some­thing about it.

On Mon­day, he launched eu­reKARE, a new Paris-based ven­ture firm aim­ing to bridge the gap be­tween acad­e­mia and in­dus­try. And he’s land­ed a $60 mil­lion Se­ries A round to get start­ed.

“Eu­ro­pean sci­ence re­mains un­der­ex­ploit­ed com­pared to coun­tries like the US, with the gap be­tween acad­e­mia and big phar­ma widen­ing over the years,” CEO Rodolphe Besserve said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER